Atovaquone Oral Suspension 750mg/5mL (Samtirel® / サムチレール内用懸濁液15%)

JPY ¥35,000

Japanese Pneumocystis Pneumonia Treatment Agent (Atovaquone 750mg/5mL). Oral suspension for treatment and prevention of Pneumocystis pneumonia, administered after meals. 5mL x 14 sachets. Mfd. by GlaxoSmithKline K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥32,200
10 - 19 12% JPY ¥30,800
20 + 18% JPY ¥28,700
SKU: SAM-750-SUSP Category:

Description

Product Overview / 商品概要

Samtirel Oral Suspension 15% (Atovaquone 750mg/5mL) (サムチレール内用懸濁液15%)
Generic: Atovaquone / アトバコン
Therapeutic Category: Pneumocystis Pneumonia Treatment Agent / ニューモシスチス肺炎治療薬
Manufactured by: GlaxoSmithKline K.K. / グラクソ・スミスクライン株式会社

Composition & Specification / 組成・規格

Active Ingredient: Atovaquone 750mg per 1 sachet (5mL) / 1包(5mL)中 アトバコン750mg
Additives: Benzyl alcohol, Xanthan gum, Polyoxyethylene (160) polyoxypropylene (30) glycol, Saccharin sodium hydrate, Flavoring / ベンジルアルコール、キサンタンガム、ポリオキシエチレン(160)ポリオキシプロピレン(30)グリコール、サッカリンナトリウム水和物、香料
Appearance: Bright yellow suspension with a fruity aroma
外観: 果実ようの芳香がある鮮黄色の懸濁剤

Indications / 効能効果

EN: Pneumocystis jirovecii

– Pneumocystis pneumonia (PCP)
– Prevention of Pneumocystis pneumonia (PCP)
JA: 〈適応菌種〉ニューモシスチス・イロベチー
〈適応症〉
○ニューモシスチス肺炎
○ニューモシスチス肺炎の発症抑制

Dosage and Administration / 用法用量

EN:
Adults: 5mL (750mg as atovaquone) twice daily for 21 days, administered orally after meals.

Adults: 10mL (1500mg as atovaquone) once daily, administered orally after meals.
JA: 〈ニューモシスチス肺炎の治療〉
通常、成人には1回5mL(アトバコンとして750mg)を1日2回21日間、食後に経口投与する。
〈ニューモシスチス肺炎の発症抑制〉
通常、成人には1回10mL(アトバコンとして1500mg)を1日1回、食後に経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22400AMX00043
Sales Started: April 2012 / 2012年4月
Classification Code: 87629
Storage: Store at room temperature / 室温保存
Shelf Life: 12 months / 12ヵ月

Packaging / 包装

Main Package (for sale): 5mL x 14 sachets / 5mL[1包]×14
Other Available Packages (by special order): 5mL [1 sachet] x 14

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Atovaquone Oral Suspension 750mg/5mL (Samtirel® / サムチレール内用懸濁液15%)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Atovaquone Oral Suspension 750mg

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.